U.S. health regulators have authorized the use of Novavax Inc.’s COVID-19 vaccine, providing a new option that works differently than the two leading vaccines, but at a time when overall demand for vaccines and boosters is low.
The Food and Drug Administration said adults 18 and older may receive Novavax’s vaccine.
